Cardioneuroablation for reflex syncope or functional bradyarrhytmias: new insight from a single center experience
- PMID: 39872880
- PMCID: PMC11770041
- DOI: 10.3389/fcvm.2024.1526825
Cardioneuroablation for reflex syncope or functional bradyarrhytmias: new insight from a single center experience
Abstract
Background: Cardioneuroablation (CNA) is a new approach to treat reflex syncope and functional bradyarrhytmias caused by autonomic imbalance. We report our experience using CNA.
Method: From September 2022 to July 2023, we took care of 21 patients (mean age 42 ± 21 years; 62% male) affected by reflex syncope or functional bradyarrhythmias. All patients underwent CNA under conscious sedation targeting the superior and/or inferior paraseptal ganglionated plexus (GPs).
Results: Nine patients were affected by vasovagal syncope (VVS) and twelve by functional bradyarrhythmias. In 3 cases (14%) the ablation was performed only on the GPs of the right atrium, while in the remaining 86% of cases we performed biatrial lesions. As regards the acute results, we highlighted an increase in sinus heart rate (12 ± 15 bpm, p = 0.001), a shortening of the PQ interval (-18 ± 18 msec, p < 0.001), a reduction of the correct sinus node recovery times (cSNRT) (-142 ± 204 msec, p = 0.114), a shortening of the AH interval (-31 ± 26 msec, p = 0.008), a reduction of the effective refractory period of the atrio-ventricular node (-156; interquartile range from -30 to -160 msec, p = 0.042) and an increase in the Wencheback point (27 ± 20 bpm, p < 0.001). At follow-up, a single patient, due to persistent symptoms and bradyarrhythmic disorder, underwent permanent pacemaker implantation; no other patient had recurrence of syncope, and all remained persistently asymptomatic.
Conclusion: Our results confirm the efficacy and safety of CNA for the treatment of VVS and functional bradyarrhythmias, although further studies are needed to support these findings.
Keywords: atrio-ventricular block; bradycardia; cardioneuroablation; catheter ablation; neuromodulation; reflex syncope.
© 2025 Valenti, Di Monaco, Romanazzi, Vitulano, Troisi, Quadrini, Vitullo, Sgarra, Caruso, Anzelmo, Guida, Brunetti and Grimaldi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Aksu T, Brignole M, Calo L, Debruyne P, Di Biase L, Deharo JC, et al. Cardioneuroablation for the treatment of reflex syncope and functional bradyarrhythmias: a scientific statement of the European heart rhythm association (EHRA) of the ESC, the heart rhythm society (HRS), the Asia pacific heart rhythm society (APHRS) and the Latin American heart rhythm society (LAHRS). Europace. (2024) 26(8):euae206. 10.1093/europace/euae206 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
